Introduction: Pompe disease (PD) is a rare, progressive, and often debilitating lysosomal storage disorder caused by mutations in the gene encoding acid alpha-glucosidase (GAA), leading to the accumulation of glycogen in muscle tissues (1). Enzyme replacement therapy (ERT) with recombinant human GAA, such as alglucosidase alfa, has been the primary
Characteristics, Outcomes and Predictors of Long-Term Mortality for Patients Hospitalized for Acute Heart Failure
150 Reached
ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes
Catheter Ablation for Atrial Fibrillation with HF
691 Reached
Male with Urethral Bleeding due to Insertion of Telephone Wire in Urethra
2465 Reached4 Comments6 Likes
Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes